Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/AKILI-INC-142714811/actualite/Akili-annonce-les-resultats-positifs-de-l-essai-clinique-de-phase-3-de-Shionogi-sur-la-version-loca-46038287/?utm_source=whatsapp&utm_medium=social&utm_campaign=share